Updated
Reviewed by Vidhi Upadhyay
Africa Pet Pharmaceuticals Market Industry Trends and Forecast to 2034: Segmented by (Product, Animal, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$354.9 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $312.2 Mn | — | — |
| 2025 (base) | $338.1 Mn | +$25.9 Mn | — |
| 2026 (forecast) | $366.2 Mn | +$28.1 Mn | +8.3% |
| 2027 (forecast) | $396.6 Mn | +$30.4 Mn | +17.3% |
| 2028 (forecast) | $429.5 Mn | +$32.9 Mn | +27% |
| 2029 (forecast) | $465.2 Mn | +$35.7 Mn | +37.6% |
| 2030 (forecast) | $503.8 Mn | +$38.6 Mn | +49% |
| 2031 (forecast) | $545.6 Mn | +$41.8 Mn | +61.4% |
| 2032 (forecast) | $590.9 Mn | +$45.3 Mn | +74.7% |
| 2033 (forecast) | $639.9 Mn | +$49.0 Mn | +89.2% |
| 2034 (forecast) | $693.0 Mn | +$53.1 Mn | +105% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US
$9.85 Bn
China
$2.09 Bn
Canada
$1.83 Bn
Japan
$1.48 Bn
Germany
$806.1 Mn
France
$702.2 Mn
UK
$535.3 Mn
Italy
$551.1 Mn
Ecuador
$533.3 Mn
Brazil
$521.7 Mn
Spain
$447.8 Mn
Saudi Arabia
$437.5 Mn
India
$380.1 Mn
Mexico
$345.1 Mn
Australia
$245.7 Mn
Russia
$234.6 Mn
New Zealand
$210.8 Mn
South Africa
$175.2 Mn
UAE
$102.1 Mn
Egypt
$62.0 Mn
Philippines
$46.5 Mn
Malaysia
$34.5 Mn
Hong Kong
$33.3 Mn
Singapore
$31.1 Mn
Thailand
$25.4 Mn
Kenya
$18.6 Mn
| Market size, 2025 | $338.1 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $693.0 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 8.3% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product and animal (see all) |
| Key players | Zoetis, Inc, Elanco, Boehringer Ingelheim GmbH, Merck & Co., Inc., Virbac (see all) |
| Regulator in Africa | AMASource: African Union, African Medicines Agency treaty. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Pet pharmaceuticals treat dogs, cats and other pets for parasites, pain, allergies, infections and chronic diseases.
Key segments of the pet Pharmaceuticals market include product (Parasiticides, Anti-Inflammatories and Antibiotics) and animal (Dogs, Cats and Others).
More pets per household, owners treating pets as family, livestock disease risks and the One Health approach linking animal and human health are driving the pet Pharmaceuticals market.
Pet insurance, diagnostics and vaccines for emerging animal diseases give the pet Pharmaceuticals market room to grow.
Cost-sensitive farmers, fewer vets in rural areas, rules on antibiotic use in animals and slow approvals hold back the pet Pharmaceuticals market.
The pet Pharmaceuticals market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
The African Medicines Agency (AMA), set up by an African Union treaty in force since November 2021, aims to bring the work of national regulators together.[1] In some of the countries we cover here, medicines are approved by EDA (Egypt)[2], PPB (Kenya)[3] and SAHPRA (South Africa)[4]. How care is paid for in some of these countries: universal health insurance (Egypt)[5], the SHA (Kenya)[6] and planned National Health Insurance (South Africa)[7].
[1] African Union, African Medicines Agency treaty. Checked 14 Nov 2026.
[2] Egyptian Drug Authority. Checked 14 Nov 2026.
[3] Pharmacy and Poisons Board. Checked 14 Nov 2026.
[4] South African Health Products Regulatory Authority. Checked 14 Nov 2026.
[5] Universal Health Insurance Authority. Checked 14 Nov 2026.
[6] Social Health Authority. Checked 14 Nov 2026.
[7] National Department of Health. Checked 14 Nov 2026.
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for pet Pharmaceuticals. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Africa.
What doctors and scientists are doing in Pet Pharmaceuticals right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
Africa · 2 shared keywords
Africa · 1 shared keyword
Africa · 1 shared keyword
Africa · 1 shared keyword
Africa · 1 shared keyword
Africa · 1 shared keyword
OTC & Nutraceuticals · Africa
Public Health · Africa
Public Health · Africa
Healthcare Services · Africa
Public Health · Africa
Medical Devices · Africa